Browsing Tag
Chronic Lymphocytic Leukaemia
1 post
$IMU rises after Imugene wins FDA Fast Track status for allogeneic CAR T therapy in CLL and MZL
Imugene won FDA Fast Track status for azer-cel in blood cancers. Find out what the $IMU regulatory boost means for investors.